BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23100326)

  • 1. Bone marrow transplantation improves the outcome of Atm-deficient mice through the migration of ATM-competent cells.
    Pietzner J; Baer PC; Duecker RP; Merscher MB; Satzger-Prodinger C; Bechmann I; Wietelmann A; Del Turco D; Doering C; Kuci S; Bader P; Schirmer S; Zielen S; Schubert R
    Hum Mol Genet; 2013 Feb; 22(3):493-507. PubMed ID: 23100326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of ATM protein and residual kinase activity correlates with the phenotype in ataxia-telangiectasia: a genotype-phenotype study.
    Verhagen MM; Last JI; Hogervorst FB; Smeets DF; Roeleveld N; Verheijen F; Catsman-Berrevoets CE; Wulffraat NM; Cobben JM; Hiel J; Brunt ER; Peeters EA; Gómez Garcia EB; van der Knaap MS; Lincke CR; Laan LA; Tijssen MA; van Rijn MA; Majoor-Krakauer D; Visser M; van 't Veer LJ; Kleijer WJ; van de Warrenburg BP; Warris A; de Groot IJ; de Groot R; Broeks A; Preijers F; Kremer BH; Weemaes CM; Taylor MA; van Deuren M; Willemsen MA
    Hum Mutat; 2012 Mar; 33(3):561-71. PubMed ID: 22213089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose irradiation prior to bone marrow transplantation results in ATM activation and increased lethality in Atm-deficient mice.
    Pietzner J; Merscher BM; Baer PC; Duecker RP; Eickmeier O; Fußbroich D; Bader P; Del Turco D; Henschler R; Zielen S; Schubert R
    Bone Marrow Transplant; 2016 Apr; 51(4):560-7. PubMed ID: 26752140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow transplantation restores immune system function and prevents lymphoma in Atm-deficient mice.
    Bagley J; Cortes ML; Breakefield XO; Iacomini J
    Blood; 2004 Jul; 104(2):572-8. PubMed ID: 15044255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype.
    Micol R; Ben Slama L; Suarez F; Le Mignot L; Beauté J; Mahlaoui N; Dubois d'Enghien C; Laugé A; Hall J; Couturier J; Vallée L; Delobel B; Rivier F; Nguyen K; Billette de Villemeur T; Stephan JL; Bordigoni P; Bertrand Y; Aladjidi N; Pedespan JM; Thomas C; Pellier I; Koenig M; Hermine O; Picard C; Moshous D; Neven B; Lanternier F; Blanche S; Tardieu M; Debré M; Fischer A; Stoppa-Lyonnet D;
    J Allergy Clin Immunol; 2011 Aug; 128(2):382-9.e1. PubMed ID: 21665257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neurological phenotype of ataxia-telangiectasia: solving a persistent puzzle.
    Biton S; Barzilai A; Shiloh Y
    DNA Repair (Amst); 2008 Jul; 7(7):1028-38. PubMed ID: 18456574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of human ATM cDNA in Atm-deficient mouse brain mediated by HSV-1 amplicon vector.
    Cortés ML; Oehmig A; Perry KF; Sanford JD; Breakefield XO
    Neuroscience; 2006 Sep; 141(3):1247-56. PubMed ID: 16809004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the porcine ATM gene: towards the generation of a novel non-murine animal model for Ataxia-Telangiectasia.
    Rogatcheva MB; Fritz KL; Rund LA; Pollock CB; Beever JE; Counter CM; Schook LB
    Gene; 2007 Dec; 405(1-2):27-35. PubMed ID: 17933474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current and potential therapeutic strategies for the treatment of ataxia-telangiectasia.
    Lavin MF; Gueven N; Bottle S; Gatti RA
    Br Med Bull; 2007; 81-82():129-47. PubMed ID: 17586848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dramatic extension of tumor latency and correction of neurobehavioral phenotype in Atm-mutant mice with a nitroxide antioxidant.
    Gueven N; Luff J; Peng C; Hosokawa K; Bottle SE; Lavin MF
    Free Radic Biol Med; 2006 Sep; 41(6):992-1000. PubMed ID: 16934683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ataxia-telangiectasia mutated is not required for p53 induction and apoptosis in irradiated epithelial tissues.
    Gurley KE; Kemp CJ
    Mol Cancer Res; 2007 Dec; 5(12):1312-8. PubMed ID: 18171989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrinsic mitochondrial dysfunction in ATM-deficient lymphoblastoid cells.
    Ambrose M; Goldstine JV; Gatti RA
    Hum Mol Genet; 2007 Sep; 16(18):2154-64. PubMed ID: 17606465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ataxia telangiectasia mutated (Atm) knockout mice as a model of osteopenia due to impaired bone formation.
    Hishiya A; Ito M; Aburatani H; Motoyama N; Ikeda K; Watanabe K
    Bone; 2005 Oct; 37(4):497-503. PubMed ID: 16027059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adult-onset ataxia telangiectasia due to ATM 5762ins137 mutation homozygosity.
    Sutton IJ; Last JI; Ritchie SJ; Harrington HJ; Byrd PJ; Taylor AM
    Ann Neurol; 2004 Jun; 55(6):891-5. PubMed ID: 15174027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel phenotypic marker for ATM-deficient 129S6/SvEvTac-ATMtm1Awb/J mice.
    Hibma JC; Neufeld DA; Halaby MJ; Yang DQ
    Anat Rec (Hoboken); 2007 Mar; 290(3):243-50. PubMed ID: 17525940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATM stabilizes DNA double-strand-break complexes during V(D)J recombination.
    Bredemeyer AL; Sharma GG; Huang CY; Helmink BA; Walker LM; Khor KC; Nuskey B; Sullivan KE; Pandita TK; Bassing CH; Sleckman BP
    Nature; 2006 Jul; 442(7101):466-70. PubMed ID: 16799570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different clinical and immunological presentation of ataxia-telangiectasia within the same family.
    Soresina A; Meini A; Lougaris V; Cattaneo G; Pellegrino S; Piane M; Darra F; Plebani A
    Neuropediatrics; 2008 Feb; 39(1):43-5. PubMed ID: 18504682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of Atm-/- thymic lymphoma cell proliferation in vitro and in vivo by dexamethasone.
    Kuang X; Yan M; Liu N; Scofield VL; Qiang W; Cahill J; Lynn WS; Wong PK
    Cancer Chemother Pharmacol; 2005 Mar; 55(3):203-12. PubMed ID: 15570424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic Stem Cell Transplantation Restores Naïve T-Cell Populations in
    Duecker R; Baer PC; Buecker A; Huenecke S; Pfeffermann LM; Modlich U; Bakhtiar S; Bader P; Zielen S; Schubert R
    Front Immunol; 2019; 10():2785. PubMed ID: 31849966
    [No Abstract]   [Full Text] [Related]  

  • 20. Modeling ATM mutant proteins from missense changes confirms retained kinase activity.
    Barone G; Groom A; Reiman A; Srinivasan V; Byrd PJ; Taylor AM
    Hum Mutat; 2009 Aug; 30(8):1222-30. PubMed ID: 19431188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.